Department of Health. Guidelines for offering voluntary named HIV antibody testing to women receiving antenatal care.London: Department of Health, 1992. (PL/CO(92)5.).
2.
SelwynPAAntonielloP.Reproductive decision-making among women with HIV infection. In: JohnsonMAJohnstoneFD, eds. HIV infection in women.London: Churchill Livingstone, 1993:173–86.
3.
AlgerLSFarleyJJRobinsonBAHinesSEBerchinJMJohnsonJP. Interactions of human immunodeficiency virus infection and pregnancy. Obstet Gynecol1993;82:787–96.
4.
NewellMLPeckhamCS. Risk factors for vertical transmission of HIV-1 and early markers of infection in children. AIDS1993;7:S591–7.
5.
European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet1994;343:1464–7.
6.
DunnDTNewellMLMayauxMJMode of delivery and vertical transmission of HIV-1: A review of prospective studies. Journal of Acquired Immune Deficiency Syndromes. In press.
7.
Centers for Disease Control. Zidovudine for the prevention of HIV transmission from mother to infant. Morb Mortal Wkly Rep1994;43:285–7.
8.
European Collaborative Study. Natural history of vertically acquired HIV-1 infection. Pediatrics. In press.
9.
Concorde Coordinating Committee. Concorde: MRC/ANRS randomized double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet1994;343:871–81.
10.
LenderkingWRGelberRDCottonDJEvaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. N Engl J Med1994;330:738–43.